Measuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to SCRMC faculty member Ian Duncan at …
News
UW researchers use stem cells to develop vocal folds in a dish
New research by SCRMC faculty member Susan Thibeault published in Nature Communications removes one of the challenges that has delayed the development of new therapies for laryngeal disease: the lack of a reliable model researchers …
Jonathan Hernández named Chief Scientific Officer at Riordan Technologies
Jonathan J. Hernández, Ph.D., has been named chief scientific officer at Riordan Technologies in the Dallas/Fort Worth area. Jonathan was a postdoctoral fellow in the lab of J. Carter Ralphe, M.D., associate professor and chief …
Graduate Student Eileen Lynch featured in Disease Models and Mechanisms
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first …
Moving beyond hype: Could one-two treatment restore damaged heart muscle?
A heart attack causes a loss of muscle and leaves the heart with a scar that does not contract and so impairs the heart’s pumping function, says Tim Kamp, professor of medicine who is co-leader …
Tiny capsules packed with gene-editing tools offer alternative to viral delivery of gene therapy
New tools for editing genetic code offer hope for new treatments for inherited diseases, some cancers, and even stubborn viral infections. But the typical method for delivering gene therapies to specific tissues in the body …
Award-winning Grad Student Research Could Benefit Industry
Three members of UW-Madison Mechanical Engineering Professor, and SCRMC faculty member, Lih-Sheng (Tom) Turng’s research group at the Wisconsin Institute for Discovery won top awards for their exceptional research papers at the Society of Plastics Engineers annual technical conference in Detroit in March 2019.
Jacques Galipeau: Cellular pharmaceuticals meet the Wisconsin Idea
Traditionally, drug development arises from a university discovery for which a pharmaceutical company acquires the rights and thereafter navigates the path to market approval. This process of shepherding a therapeutic discovery to become a U.S. …
WARF Accelerator Award
SCRMC Faculty Member Peiman Hematti has been awarded a WARF Accelerator Project titled, “Development of Therapeutic Macrophages for Radiation Injuries.”
Statement from the Department of Health and Human Services: HHS update on fetal tissue research
Statement from the Department of Health and Human Services In September 2018, the Department of Health and Human Services (HHS) terminated a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration that …